Paratek Pharmaceuticals at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Paratek Pharmaceuticals brings 1 presentation to IDWeek 2026 in Washington, and exhibits at Booth 1725, 1824. Its program centres on the antibiotic omadacycline. Lab testing measures its activity against Borrelia species and Bartonella henselae.

OrganizationIDWeek 2026 Attendance
Paratek Pharmaceuticals
King of Prussia, PA
paratekpharma.com
Biotech
Biopharmaceutical company developing treatments for hard-to-treat diseases in hospital and community settings.
Booth
Exhibiting at Booth 1725, 1824
Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm
Poster
Thu Oct 22
12:15pm–1:30pm
In Vitro Activity of Omadacycline Against Borrelia spp. and Bartonella henselae
Poster Hall B-C · Poster P-122
A4. Treatment of antimicrobial resistant infections

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Paratek Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction